Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest half life time in humans after IV administration.
Constraint: You must select all options from a, b, c, d, or e without using any other words.
Options:
a.) COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1
b.) O=C(O)[C@@H]1C[C@@H](C2CCCCC2)CN1C(=O)CP(=O)(O)CCCCc1ccccc1
c.) CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
d.) Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1
e.) CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2
Answer: c
Task: Please answer the multiple choice question.
Question: Rank these molecules from shortest to longest {half_life_duration__names__noun}.
Constraint: You must select all options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%half_life_duration%}
Answer: {%multiple_choice_result}
methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate